March 6, 2013

FDA panel sees risk in long-used osteoporosis drug

By Logan Lafferty

A panel of federal health experts says a long-established bone strengthening drug should no longer be used by women because there is little evidence it works and it may actually increase the risk of cancer…"We have a whole lot of patients who can't take the other drugs, and I think our patients would be in worse shape without this," said Bart Clark, professor at the Mayo Clinic College of Medicine in Rochester, Minn.

Additional Coverage: ABC News, USA Today, NPR, Pioneer Press


MPR (AP) by Matthew Perrone

Tags: bone strength, Dr. Bart Clark, federal health, Mayo Clinic Rochester, MPR, osteoperosis, risk increase, Women's Health

Contact Us · Privacy Policy